Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Retroviral protease inhibiting compounds

Retroviral protease inhibiting compounds

US Patent 6284767 · Granted Sep 4, 2001

Estimated economic value: $104,254,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-hydroxytryptamine receptor 7 activity modulators and their method of use2025
Extended local release of anti-CSFR1 antibodies2025
5-hydroxytryptamine receptor 7 activity modulators and their method of use2025
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
Stable protein solution formulation containing high concentration of an anti-VEG2024
5-hydroxytryptamine receptor 7 activity modulators and their method of use2024
Cyclic di-nucleotides as stimulator of interferon genes modulators2023
Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cel2023
Tricyclic compounds as histone methyltransferase inhibitors2023
Extended local release of anti-CSFR1 antibodies2022
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2022
Substituted pyrimidines as CDK4/6 inhibitors2022